Literature DB >> 2380361

Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi.

W J Simpson1, M E Schrumpf, T G Schwan.   

Abstract

Borrelia burgdorferi is the causative agent of Lyme borreliosis, a spirochetal illness with a variety of acute clinical manifestations that may lead to debilitating neurological and arthritic complications. Diagnosis is difficult because symptoms mimic a variety of unrelated clinical conditions, spirochetes cannot always be isolated from infected patients, and current serological tests are frequently inconclusive because of the presence of cross-reacting non-B. burgdorferi antibodies. To identify antigens specific to B. burgdorferi that could be used in the serodiagnosis of Lyme borreliosis, we screened a Borrelia DNA expression library in Escherichia coli for antigens reactive with human Lyme borreliosis sera. One clone carried a 6.3-kilobase EcoRI chromosomal fragment (pSPR33), which encoded two species-specific antigens with molecular masses of 28 (P28) and 39 (P39) kilodaltons (kDa). These two antigens were immunologically distinct from OspA, OspB, and the 41-kDa flagellin. Ninety-four serum specimens from patients having Lyme borreliosis were tested for reactivity with P39. All of 33 the serum specimens with immunofluorescence assay titers of greater than or equal to 1:256, 13 of 17 serum specimens with titers of 1:128, and 14 of 44 serum specimens with titers of less than or equal to 1:64 reacted with P39. Notably, many sera reactive to P39 did not appear to react with the 41-kDa flagellin. Therefore, antibody to P39 could be mistaken for antibody to the 41-kDa flagellin in tests of human sera by Western blot (immunoblot). Twenty-five control serum specimens, which included sera from syphilitic, relapsing fever, and amyotrophic lateral sclerosis patients as well as from 10 normal individuals, did not react to P39. Our data suggest that P39 may be a useful antigen for the serological confirmation of Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380361      PMCID: PMC267928          DOI: 10.1128/jcm.28.6.1329-1337.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  MODIFICATIONS OF THE RAPID PLASMA REAGIN (RPR) CARD TEST FOR SYPHILIS, FOR USE IN LARGE SCALE TESTING.

Authors:  J PORTNOY
Journal:  Am J Clin Pathol       Date:  1963-11       Impact factor: 2.493

2.  Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody.

Authors:  A G Barbour; S L Tessier; W J Todd
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

3.  Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete.

Authors:  A G Barbour; W Burgdorfer; E Grunwaldt; A C Steere
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

4.  A DNA substitution in the group A streptococcal bacteriophage SP24.

Authors:  J G Spanier; P P Cleary
Journal:  Virology       Date:  1983-10-30       Impact factor: 3.616

5.  Variation in a major surface protein of Lyme disease spirochetes.

Authors:  A G Barbour; S L Tessier; S F Hayes
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

6.  The spirochetal etiology of Lyme disease.

Authors:  A C Steere; R L Grodzicki; A N Kornblatt; J E Craft; A G Barbour; W Burgdorfer; G P Schmid; E Johnson; S E Malawista
Journal:  N Engl J Med       Date:  1983-03-31       Impact factor: 91.245

7.  Lyme disease-a tick-borne spirochetosis?

Authors:  W Burgdorfer; A G Barbour; S F Hayes; J L Benach; E Grunwaldt; J P Davis
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

8.  Lyme arthritis in the Hunter Valley.

Authors:  A Stewart; J Glass; A Patel; G Watt; A Cripps; R Clancy
Journal:  Med J Aust       Date:  1982-02-06       Impact factor: 7.738

9.  Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.

Authors:  A C Steere; S E Malawista; D R Snydman; R E Shope; W A Andiman; M R Ross; F M Steele
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb

10.  Immunochemical analysis of Lyme disease spirochetes.

Authors:  A G Barbour
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  69 in total

1.  Laboratory confirmation of Lyme disease.

Authors:  T G Schwan; W J Simpson; P A Rosa
Journal:  Can J Infect Dis       Date:  1991

Review 2.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

3.  Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection.

Authors:  B P Fung; G L McHugh; J M Leong; A C Steere
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

4.  Tick transmission of Borrelia burgdorferi to inbred strains of mice induces an antibody response to P39 but not to outer surface protein A.

Authors:  W T Golde; K J Kappel; G Dequesne; C Feron; D Plainchamp; C Capiau; Y Lobet
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.

Authors:  Adam S Coleman; Utpal Pal
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

6.  Temporal analysis of the antigenic composition of Borrelia burgdorferi during infection in rabbit skin.

Authors:  Timothy R Crother; Cheryl I Champion; Julian P Whitelegge; Rodrigo Aguilera; Xiao-Yang Wu; David R Blanco; James N Miller; Michael A Lovett
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Distribution and molecular analysis of Lyme disease spirochetes, Borrelia burgdorferi, isolated from ticks throughout California.

Authors:  T G Schwan; M E Schrumpf; R H Karstens; J R Clover; J Wong; M Daugherty; M Struthers; P A Rosa
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

8.  The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies.

Authors:  M Scriba; J S Ebrahim; T Schlott; H Eiffert
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.

Authors:  S W Barthold; L K Bockenstedt
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes.

Authors:  R Wallich; C Helmes; U E Schaible; Y Lobet; S E Moter; M D Kramer; M M Simon
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.